000 01218 a2200301 4500
005 20250515170240.0
264 0 _c20090609
008 200906s 0 0 eng d
022 _a1090-2104
024 7 _a10.1016/j.bbrc.2009.04.098
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReichling, Laurie J
245 0 0 _aLeucine-rich repeat kinase 2 mutants I2020T and G2019S exhibit altered kinase inhibitor sensitivity.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cJun 2009
300 _a255-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenosine Triphosphate
_xchemistry
650 0 4 _aAmino Acid Substitution
650 0 4 _aHumans
650 0 4 _aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2
650 0 4 _aMutation
650 0 4 _aParkinson Disease
_xenzymology
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProtein Serine-Threonine Kinases
_xantagonists & inhibitors
700 1 _aRiddle, Steven M
773 0 _tBiochemical and biophysical research communications
_gvol. 384
_gno. 2
_gp. 255-8
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2009.04.098
_zAvailable from publisher's website
999 _c18828161
_d18828161